InvestorsHub Logo
Followers 63
Posts 8502
Boards Moderated 0
Alias Born 01/10/2014

Re: DOGONE post# 116603

Monday, 07/12/2021 1:42:39 PM

Monday, July 12, 2021 1:42:39 PM

Post# of 198086
Excellent post DOGONE ! Glad it was stickied so I didn't miss it.

A new challenger is stepping into the ring with an HIV treatment that not only controls the disease but also boosts the immune system, something none of the HIV drugs can claim. Enzolytics (ENZC) HIV therapy is called ITV-1, which has a solid safety profile and demonstrated efficacy in HIV.

So for now, Gilead is still heavily dependent on HIV, and Enzolytics is threatening the cornerstone of its business.

https://insiderfinancial.com/enzolytics-enzc-takes-on-hiv-heavyweight-gilead-sciences/181723/

I don't call people names or use vulgar language in Public or Private. Once you cuss and call someone names you lost the argument and also lost your class. You have nothing else left to defend your comment. Statements are my Opinion only. Do your own DD.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News